Are you a newbie to Australia. Click here to know more about Studying in Australia, About living here, getting your first job and planning for Permanent residency.
Guide to OZ Jobs/Rooms listingsHere’s what you need to know about the coronavirus right now: Russia and Chinese vaccines raise doubts High-profile novel coronavirus vaccines developed in Russia and China share a potential shortcoming: They are based on adenovirus type 5, or Ad5, a common cold virus that many people have been exposed to, potentially limiting their effectiv...
BEIJING: Sinovac Biotech Ltd’s coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said. China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical...
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer. More than 64,000 patients in the US have been given convalescent plasma, a century-old approach to fend off ...
MOSCOW: Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people. President Vladimir Putin announced the Health Ministry’s approval and said one of his two adult daughters already was inoculated. He sai...
WASHINGTON: US President Donald Trump said on Thursday it was possible the United States would have a coronavirus vaccine before the Nov. 3 election, a more optimistic forecast on timing than anything suggested by his own White House health experts. Asked on the Geraldo Rivera radio program when a vaccine might be ready, Trump said, ...
WASHINGTON: Dr. Anthony Fauci said Friday that he remains confident that a coronavirus vaccine will be ready by early next year, telling lawmakers that a quarter-million Americans already have volunteered to take part in clinical trials. But if the future looks encouraging, public health alarms are still going off in the present. Officials testifyi...
Q2 profit and sales beat on portfolio strength Reiterates 2020 guidance for what has been a strong year Optimism around AZ/Oxford coronavirus vaccine high Shares rise as much as 3% in morning trade Britain’s AstraZeneca bettered second-quarter sales and profit estimates on Thursday, thanks to strong sales during the lockdowns from the drugm...
WASHINGTON: Western governments on Thursday accused hackers believed to be part of Russian intelligence of trying to steal valuable private information about a coronavirus vaccine, calling out the Kremlin in an unusually detailed public warning to scientists and medical companies. The alleged culprit is a familiar foe. Intelligence agencies in the ...
BEIJING: China National Biotec Group (CNBG) said on Sunday that early human test results for a coronavirus vaccine candidate suggested it could be safe and effective, the second vaccine candidate from the firm to show encouraging results in a clinical trial. The experimental shot, developed by a Beijing-based unit of CNBG, has induced h...
SAO PAULO: Oxford University this weekend started human clinical trials for a potential coronavirus vaccine in Brazil, sponsor Lemann Foundation said in a statement late on Monday. Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro. Brazil’s health regulator Anvisa approved human clinical tria...